Zynext Ventures and Zydus Lifesciences are in a strategic position to help us achieve these goals." Sickle cell disease is a devastating and debilitating genetic condition that affects up to 10 ...

Zydus Lifesciences share price today, March 19: The share price of Zydus Lifesciences has risen by 1.8% in the past five trading sessions. (Image: Freepik) Zydus Lifesciences rose 3% to an intra ...

Homegrown pharma company Zydus Lifesciences Ltd announced on Tuesday its strategic move into the medical technology sector through the acquisition of a controlling stake in French orthopaedics firm ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Zydus Lifesciences Limited announced on Tuesday that it has secured the final approval from the United States Food and Drug Administration (USFDA) for manufacturing and marketing apalutamide ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new tab said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA), opens new tab for 256.8 million ...

Zydus Lifesciences share price extended the gains on third consecutive session on March 19, rising more than 1 percent after company received final approval from USFDA for Apalutamide Tablets ...

Zydus Lifesciences Ltd on Tuesday, March 11, said that its board of directors has approved an acquisition of 85.6% equity stake in Amplitude Surgical SA, France. The deal is subject to signing a ...

Zydus Lifesciences announced today it will develop the world’s first combination vaccine targeting both typhoid fever and shigellosis, with financial backing from the Bill & Melinda Gates ...

Zydus Lifesciences share price gained more than 3 percent in the early trade on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg ...